Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial

Robert Zilberszac, Rishi Chandiramani, Christian Hengstenberg, Samantha Sartori, Davide Cao, Jaya Chandrasekhar, Ulrich Schafer, Didier Tchetche, Roberto Violini, Raban Jeger, Eric Van Belle, Peter Boekstegers, Rainer Hambrecht, Christophe Tron, Nicolas Dumenteil, Axel Linke, Jurriën M. ten Berg, Efthymios N. Deliargyris, Prodromos Anthopoulos, Roxana MehranGeorge Dangas

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences